Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metabolic Dysfunction Associated Steatohepatitis”

161 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 161 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07193927
What this trial is testing

Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatty Liver Disease, NonalcoholicOverweight (BMI > 25)
AB Biotics, SA 60
Not applicableEnrolling By InvitationNCT06953830
What this trial is testing

Optimal Measurement of Spleen Stiffness Among Veterans With Metabolic Dysfunction-Associated Steatotic Liver Disease

Who this might be right for
Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD)
William Jennings Bryan Dorn VA Medical Center 100
Not applicableUnknownNCT05734599
What this trial is testing

NMR-based Metabolic Profiling Identifies High Risk of MAFLD Patients With Advanced Fibrosis

Who this might be right for
Metabolic Dysfunction-associated Fatty Liver DiseaseMetabolic Disease
Huazhong University of Science and Technology 1,194
Not applicableNot Yet RecruitingNCT07177963
What this trial is testing

CPET-based HIIT for MAFLD

Who this might be right for
Metabolic Dysfunction-Associated Fatty Liver Disease
Tang Yida 54
Large-scale testing (Phase 3)Looking for participantsNCT07165028
What this trial is testing

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease
Eli Lilly and Company 4,500
Early research (Phase 1)Not Yet RecruitingNCT07358546
What this trial is testing

Efimosfermin Alfa in Adults With Hepatic Impairment

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 32
Testing effectiveness (Phase 2)Looking for participantsNCT06939816
What this trial is testing

Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)

Who this might be right for
Chronic Kidney Disease Stage 2Chronic Kidney Disease Stage 3Metabolic Dysfunction-Associated Steatohepatitis
Enyo Pharma 60
Not applicableNot Yet RecruitingNCT07313007
What this trial is testing

Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis (MASH)
Hospices Civils de Lyon 24
Post-approval studies (Phase 4)Enrolling By InvitationNCT06845345
What this trial is testing

Effect of Mediterranean Diet Combined With Intermittent Fasting on Liver Fibrosis Compared to Naltrexone/Bupropion in People With Cardiometabolic Risk Factors (MEDFAST-study)

Who this might be right for
Diabetes Mellitus, Type 2Liver FibrosisLiver Steatoses+9 more
Carmen Dietvorst 70
Not applicableUnknownNCT05880316
What this trial is testing

Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting

Who this might be right for
Fatty Liver Disease
Universiti Kebangsaan Malaysia Medical Centre 100
Not applicableStudy completedNCT05804955
What this trial is testing

Alpha-Glutathione-S-Transferase (AlphaGST) and MARINA Index in Metabolic-Dysfunction-Associated-Steatotic-Liver-Disease (MASLD)

Who this might be right for
Fatty Liver
University of Campania Luigi Vanvitelli 260
Testing effectiveness (Phase 2)Looking for participantsNCT06920043
What this trial is testing

Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis
Boston Pharmaceuticals 42
Testing effectiveness (Phase 2)Looking for participantsNCT07288138
What this trial is testing

A Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
Eccogene 160
Post-approval studies (Phase 4)Not Yet RecruitingNCT07289750
What this trial is testing

The Effect of Alogliptin Combined With Actoplus Met on Glucose and Lipid Metabolism and Pancreatic Function in Patients With T2DM Complicated With MAFLD.

Who this might be right for
T2DMMAFLD
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 80
Not applicableNot Yet RecruitingNCT07241195
What this trial is testing

A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes

Who this might be right for
NAFLD and NASHNAFLD( Non-alcoholic Fatty Liver Disease )NAFLD Cirrhosis
The Affiliated Hospital of Hangzhou Normal University 20,000
Not applicableStudy completedNCT06741111
What this trial is testing

A Real-world Assessment in Implementation of the MASH Patient Care Pathway in Chinese Population Using the Meinian Health Check-up Database

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) & Steatohepatitis (MASH)
Novo Nordisk A/S 1,233,970
Not applicableNot Yet RecruitingNCT06749704
What this trial is testing

Effect of High Protein Diet on Hepatic Steatosis in Patients With MAFLD

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver Disease
Institute of Liver and Biliary Sciences, India 140
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07016633
What this trial is testing

To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in Patients With MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Changchun Intellicrown Pharmaceutical Co. LTD 40
Large-scale testing (Phase 3)Looking for participantsNCT06632457
What this trial is testing

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim 1,590
Not applicableNot Yet RecruitingNCT06797596
What this trial is testing

Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.

Who this might be right for
Liver Fibrosis Due to NASHMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseAlcohol Liver Disease
Fibronostics USA, Inc 100
Load More Results